You Have the Right to Remain Silent

This morning I spent an hour debating David Cole of Georgetown on Wisconsin Public Radio. The question was whether we should read Miranda rights to suspected terrorists. Not a lot of sparks. I tend to believe that the public safety exception to Miranda should be broad enough to include (in some way that requires further definition) questioning undertaken to protect the public from an ongoing terrorist operation or to determine that there is no such ongoing operation. I don’t agree that Miranda is completely off the table just because the suspected charge is terrorism. While Professor Cole wants a more immediate geographically bound exception that I’d draft, the devil is in the details.

On more fundamental level, it doesn’t seem that deferring Miranda rights is among the most difficult legal trade-offs in the war on terror. Both its value to national security and its imposition on the rights of suspects is limited.

I would have preferred to discuss  Holder v. Humanitarian Law Project, a case currently pending before the Supreme Court in which Professor Cole represents the plaintiffs.

Continue ReadingYou Have the Right to Remain Silent

Can New Patent Rules Help to Reduce Biopiracy?

Endowed with extraordinary genetic diversity, the world’s tropical rainforests have produced the raw material for many highly profitable pharmaceuticals.  Yet, the nations in which the rainforests are located — many of which are among the poorest in the world — often realize little economic benefit.  “Bioprospectors” have traditionally had little difficulty operating outside the legal regulation of source nations.  And, once biological materials are transported to the developed world, they may be made the basis for legally enforceable patents there.  Then, adding insult to injury — or perhaps more accurately, injury to insult — the patents may impair the ability of source nations to use their own genetic resources.  To critics, this dynamic — often labeled “biopiracy” — calls to mind the long tradition of exploitative north-south relationships going back to colonial days. 

The Convention on Biological Diversity aims to strengthen the position of source nations by requiring bioprospectors to obtain prior informed consent before using materials from other nations.  However, the treaty has a weak enforcement mechanism, and the United States is not even a party to it.

Responding to the weaknesses of the CBD, 3L Laura Grebe has an interesting new proposal to incorporate the prior informed consent concept into U.S. patent law.  Her proposal is described and defended in a new paper on SSRN entitled “Requiring Genetic Source Disclosure in the United States.”  In essence, Laura would require patent applicants to disclose the origin of their genetic materials and whether they obtained prior informed consent from the source nations.  Among other things, she hopes that U.S. reforms along these lines would become a model for other nations.

The abstract to Laura’s paper appears after the jump. 

Continue ReadingCan New Patent Rules Help to Reduce Biopiracy?

The Beginning of Health Reform

On March 23, 2010, President Obama made history by signing into law the Patient Protection and Affordable Care Act, a landmark statute that aims to fundamentally reform virtually all aspects of the nation’s health care system. The health reform law is fairly viewed as the most sweeping social policy legislation since Lyndon Johnson’s Great Society initiatives.

There are many specific goals of the statute, including expanding health insurance coverage, increasing access to health care services, improving health care quality, enhancing the value of care received, eliminating racial and ethnic health disparities, strengthening the public health infrastructure, expanding and diversifying the health care workforce, and encouraging consumer and patient wellness at home and at work. More fundamentally, however, the goal of health reform is to restructure the current health care system into one that operates more fairly, more efficiently, and with more accountability on the part of the many different stakeholders involved.

Although passage of the law was 14 months in the making, the statute itself is merely the first step. Next comes the truly challenging part: translating the enormous (and enormously complex) law into a transformed health system. 

Continue ReadingThe Beginning of Health Reform